Literature DB >> 12552473

A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia.

C M H Bailey1, S Saha, T R Magee, R B Galland.   

Abstract

OBJECTIVES: to determine management of patients with critical lower limb ischaemia (CLI) from first presentation to investigation and treatment.
DESIGN: prospective study of critical ischaemia patients.
METHODS: one-year prospective survey (May 2000-May 2001). Follow-up 3-15 months.
RESULTS: some 873 arterial cases presented, 134 patients had CLI. Of the latter 49% were men, 30% diabetic, the median age was 81 years. Only 15 (24%) of 62 cases were referred to outpatients as urgent. Patients waited a median of 25 days (range 1-100) to be seen in outpatients, and had symptoms for a median of 8 weeks. Treatment was conservative for 70 patients, and 11 primary amputations, six secondary amputations, and 62 revascularisation procedures (34 operative, 28 percutaneous transluminal angioplasty) were performed. At follow-up (3-15 months, median 9 months), rates of major amputation and death were 12 and 27% respectively. Significantly more diabetics underwent major amputation (p < 0.02) than non diabetics. Patients presenting with ulceration or gangrene were at greater risk of death than those with rest pain alone (p < 0.01).
CONCLUSION: patients with CLI often have symptoms for many weeks before being seen by a specialist, and 76% are referred as non-urgent cases. This compares with patients with suspected malignant disease in the U.K. who are required to be seen within 2 weeks.

Entities:  

Mesh:

Year:  2003        PMID: 12552473     DOI: 10.1053/ejvs.2002.1817

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores.

Authors:  Robert Ward; Joie Dunn; Leonardo Clavijo; David Shavelle; Vincent Rowe; Karen Woo
Journal:  Ann Vasc Surg       Date:  2016-08-19       Impact factor: 1.466

2.  The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries.

Authors:  Aleksander Falkowski; Wojciech Poncyljusz; Grazyna Wilk; Małgorzata Szczerbo-Trojanowska
Journal:  Eur Radiol       Date:  2008-11-26       Impact factor: 5.315

3.  Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Hiroki Takahashi; Gensai Yamaura; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Isao Kubota
Journal:  Heart Vessels       Date:  2016-06-01       Impact factor: 2.037

Review 4.  Building a Critical Limb Ischemia Program.

Authors:  Andrew M Galmer; Samy M Selim; Jay Giri; Joe F Lau; Mitchell D Weinberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

5.  The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia.

Authors:  Mitsuyoshi Takahara; Hideaki Kaneto; Osamu Iida; Shin-ichi Gorogawa; Naoto Katakami; Taka-aki Matsuoka; Masahiko Ikeda; Iichiro Shimomura
Journal:  Diabetes Care       Date:  2010-09-15       Impact factor: 19.112

6.  Clinical outcomes of infrapopliteal angioplasty in patients with critical limb ischemia.

Authors:  Hyeon Min Ryu; Jung-Sun Kim; Young Guk Ko; Myeong-Ki Hong; Yangsoo Jang; Donghoon Choi
Journal:  Korean Circ J       Date:  2012-04-26       Impact factor: 3.243

7.  Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Gensai Yamaura; Akira Funayama; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Isao Kubota
Journal:  BBA Clin       Date:  2015-06-18

8.  Clinical characteristics of patients with Rutherford category IV, compared with V and VI.

Authors:  Taketsugu Tsuchiya; Osamu Iida; Tatsuya Shiraki; Yoshimitsu Soga; Keisuke Hirano; Kenji Suzuki; Terutoshi Yamaoka; Yusuke Miyashita; Michihiko Kitayama; Koji Kajinami
Journal:  SAGE Open Med       Date:  2015-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.